The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions.If you have any queries about the SPCs on our website then please e-mail vetinfo@hpra.ie


GALLIVAC IB88 NEO effervescent tablet for suspension for nebulisation for chickens

. Effervescent tablet

Boehringer Ingelheim Vetmedica GmbHVPA10454/056/001

Main Information

Trade NameGALLIVAC IB88 NEO effervescent tablet for suspension for nebulisation for chickens
Active SubstancesLive attenuated coronavirus, CR88121 strain
Strength.
Dosage FormEffervescent tablet
Licence HolderBoehringer Ingelheim Vetmedica GmbH
Licence NumberVPA10454/056/001

Group Information

ATC CodeQI01AD07 avian infectious bronchitis virus
Therapeutic ClassImmunological - Live Vaccine
SpeciesChickens

Status

Authorised/WithdrawnAuthorised
Licence Issued19/02/2016
Legal StatusPOM: Prescription Only Medicine as defined in relevant national legislation

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletNo document available
Public Assessment ReportPDF Version
« Back